Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first1,181 to 1,200 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| CCL21 C-C motif chemokine ligand 21 | 6366 HGNC:10620 | 1 | 261 | 0 | 0 | 3,676 | 6,067 |
| SRSF2 serine and arginine rich splicing factor 2 | 6427 HGNC:10783 | 1 | 55 | 0 | 0 | 3,042 | 6,067 |
| CLEC3B C-type lectin domain family 3 member B | 7123 HGNC:11891 | 1 | 35 | 0 | 0 | 2,324 | 6,051 |
| INHBE inhibin subunit beta E | 83729 HGNC:24029 | 1 | 43 | 0 | 0 | 3,507 | 6,039 |
| OPA1 OPA1 mitochondrial dynamin like GTPase | 4976 HGNC:8140 | 1 | 38 | 0 | 0 | 3,099 | 6,026 |
| MIR150 microRNA 150 | 406942 HGNC:31537 | 0 | 0 | 0 | 0 | 1,937 | 6,018 |
| TDO2 tryptophan 2,3-dioxygenase | 6999 HGNC:11708 | 1 | 46 | 0 | 0 | 2,245 | 6,018 |
| FOSL1 FOS like 1, AP-1 transcription factor subunit | 8061 HGNC:13718 | 1 | 54 | 0 | 0 | 3,369 | 6,017 |
| ITPR3 inositol 1,4,5-trisphosphate receptor type 3 | 3710 HGNC:6182 | 1 | 42 | 0 | 0 | 3,666 | 6,014 |
| MIR375 microRNA 375 | 494324 HGNC:31868 | 0 | 0 | 0 | 0 | 1,626 | 6,011 |
| MIR215 microRNA 215 | 406997 HGNC:31592 | 0 | 0 | 0 | 0 | 1,315 | 6,006 |
| VCAN versican | 1462 HGNC:2464 | 1 | 118 | 0 | 0 | 3,570 | 6,004 |
| PTGDR prostaglandin D2 receptor | 5729 HGNC:9591 | 1 | 44 | 3 | 23 | 2,252 | 6,002 |
| MICA MHC class I polypeptide-related sequence A | 100507436 HGNC:7090 | 1 | 145 | 0 | 0 | 2,994 | 5,986 |
| MAP3K5 mitogen-activated protein kinase kinase kinase 5 | 4217 HGNC:6857 | 1 | 54 | 1 | 9 | 2,820 | 5,983 |
| AKT3 AKT serine/threonine kinase 3 | 10000 HGNC:393 | 1 | 147 | 14 | 175 | 3,437 | 5,980 |
| NFATC1 nuclear factor of activated T cells 1 | 4772 HGNC:7775 | 1 | 30 | 0 | 0 | 3,536 | 5,979 |
| DLD dihydrolipoamide dehydrogenase | 1738 HGNC:2898 | 1 | 51 | 0 | 0 | 2,139 | 5,972 |
| PDCD6IP programmed cell death 6 interacting protein | 10015 HGNC:8766 | 1 | 40 | 0 | 0 | 2,678 | 5,967 |
| ITGA2 integrin subunit alpha 2 | 3673 HGNC:6137 | 1 | 62 | 1 | 4 | 3,634 | 5,966 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=60
{
"data": {
"total": 193990,
"results": [
{
"id": "6366",
"title": "CCL21: C-C motif chemokine ligand 21",
"summary": "NCBI Gene 6366. 1 protein, 261 patents, 0 drugs, 0 trials, 3,676 NIH grants and 6,067 papers.",
"record": "/library/genes/6366",
"gene_id": 6366,
"symbol": "CCL21",
"name": "C-C motif chemokine ligand 21",
"hgnc_id": "HGNC:10620",
"counts": {
"proteins": 1,
"patents": 261,
"drugs": 0,
"trials": 0,
"grants": 3676,
"papers": 6067
}
},
{
"id": "6427",
"title": "SRSF2: serine and arginine rich splicing factor 2",
"summary": "NCBI Gene 6427. 1 protein, 55 patents, 0 drugs, 0 trials, 3,042 NIH grants and 6,067 papers.",
"record": "/library/genes/6427",
"gene_id": 6427,
"symbol": "SRSF2",
"name": "serine and arginine rich splicing factor 2",
"hgnc_id": "HGNC:10783",
"counts": {
"proteins": 1,
"patents": 55,
"drugs": 0,
"trials": 0,
"grants": 3042,
"papers": 6067
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=61",
"request_id": "gJNUNvhafoOxaHqr"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant